Day 2 of BOPA 2017
Providing the relevant information to patients: a changing approach in Spain
Practical intricacies surrounding biosimilar adoption
ASH 2017 update on progress with novel AML treatments at MD Anderson
Naval Daver et al.
What should the future of cancer treatment and research look like?